Edelman BioScience managing director David Noble shown the door

Edelman has made the managing director of its BioScience division redundant as part of a 'restructure'.

Now overseeing BioScience division: Steven Spurr
Now overseeing BioScience division: Steven Spurr

David Noble leaves the agency this month following a three-week consultation process. He had been heading the agency’s specialist medical communications business unit for more than three years.

The division specialises in publication planning, advisory board management, meetings and symposia,
clinical trial recruitment/retention and market access support.

Responsibility for the division will be passed to Steven Spurr, who heads Edelman’s 40-strong ethical healthcare division.

Edelman UK CEO Robert Phillips said the decision had been made to make Noble’s position redundant as part of a management restructure.

‘The BioScience and Rx divisions will remain separate, but will be headed by Steve. We are reorganising
internally to have more fluent interaction between the teams,’ said Phillips.

Spurr took over as head of the UK healthcare team last year after European healthcare managing director Mike Kan was made redundant.

Noble previously worked as managing director of Hill & Knowlton’s healthcare strategic consulting and medical knowledge group before joining Edelman in 2006.

Edelman’s healthcare team moved down to the third spot in this year’s PRWeek Healthcare League tables from the second slot last year.

The division had an income of £6,815,000 in 2009, up from £6,302,000 in 2008.

Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus

Latest Articles

Max Clifford trial jury finishes sixth day of deliberations

Max Clifford trial jury finishes sixth day of deliberations

The jury in the trial of celebrity publicist Max Clifford on 11 charges of indecent assault has been sent home and will reconvene tomorrow morning for a seventh day of deliberations.

Analysis: Fishburn chiefs keep eyes on future despite mounting departures

Analysis: Fishburn chiefs keep eyes on future despite mounting departures

Fishburn's management have defended their reinvention of the 23-year-old agency amid industry mutterings, fed by a series of director-level departures, about the direction in which it is going.

Hit or Miss? EasyJet backs Shakespeare Day campaign with world record attempt

Hit or Miss? EasyJet backs Shakespeare Day campaign with world record attempt

EasyJet aimed to break the world record for the highest ever theatrical performance for Shakespeare's 450th birthday yesterday with the Reduced Shakespeare Company performing on a flight from Gatwick to Verona.

Top PRs to gather in Barcelona for inaugural PRWeek Global Congress

Top PRs to gather in Barcelona for inaugural PRWeek Global Congress

Senior executives from IBM, Nestlé, Vedanta, GE, Cargill, Philips and Allianz will be among the speakers at PRWeek's first Global Congress.